Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like Wegovy and Ozempic — when prescribed for their Food and Drug Administration ...
is one of 38 cancer centres around the world running the early-stage trial of the mRNA therapy for people with gastric and gastro-oesophageal cancer. Only 20 patients across the world who have stomach ...